These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 30012132

  • 1. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.
    Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, Merler S.
    BMC Med; 2018 Jul 17; 16(1):117. PubMed ID: 30012132
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
    Sauboin C, Holl K, Bonanni P, Gershon AA, Benninghoff B, Carryn S, Burgess MA, Wutzler P.
    BMC Infect Dis; 2019 Feb 06; 19(1):126. PubMed ID: 30727971
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.
    EBioMedicine; 2015 Oct 06; 2(10):1494-9. PubMed ID: 26629544
    [Abstract] [Full Text] [Related]

  • 9. Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
    Bilcke J, van Hoek AJ, Beutels P.
    Hum Vaccin Immunother; 2013 Apr 06; 9(4):812-22. PubMed ID: 23321955
    [Abstract] [Full Text] [Related]

  • 10. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS, King PG.
    Hum Exp Toxicol; 2014 Aug 06; 33(8):886-93. PubMed ID: 24275643
    [Abstract] [Full Text] [Related]

  • 11. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P.
    Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704
    [Abstract] [Full Text] [Related]

  • 12. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B.
    Pharmacoeconomics; 2004 Feb 14; 22(13):839-55. PubMed ID: 15329030
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Hoshi SL, Kondo M, Okubo I.
    Vaccine; 2017 May 31; 35(24):3264-3271. PubMed ID: 28479176
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.
    Hoshi SL, Seposo X, Shono A, Okubo I, Kondo M.
    Vaccine; 2019 Jun 12; 37(27):3588-3597. PubMed ID: 31153691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A systematic review of the cost effectiveness of herpes zoster vaccination.
    Szucs TD, Pfeil AM.
    Pharmacoeconomics; 2013 Feb 12; 31(2):125-36. PubMed ID: 23335045
    [Abstract] [Full Text] [Related]

  • 20. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ, Littlewood KJ, Sauboin C, Téhard B, Denis F, Boëlle PY, Alain S.
    Clin Ther; 2015 Apr 01; 37(4):816-829.e10. PubMed ID: 25726457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.